Next Article in Journal
The Mitochondrial Proteomic Signatures of Human Skeletal Muscle Linked to Insulin Resistance
Next Article in Special Issue
Optimized Protocol for Isolation of Small Extracellular Vesicles from Human and Murine Lymphoid Tissues
Previous Article in Journal
Beneficial Effects of Mineralocorticoid Receptor Antagonism on Myocardial Fibrosis in an Experimental Model of the Myxomatous Degeneration of the Mitral Valve
Previous Article in Special Issue
Small Extracellular Vesicles Isolated from Serum May Serve as Signal-Enhancers for the Monitoring of CNS Tumors

Microvesicles in Cancer: Small Size, Large Potential

Department of Medicine A, Hematology, Oncology, and Pneumology, University Hospital Münster, 48149 Münster, Germany
Department of Hematology/Medical Oncology, University Medical Center Göttingen, 37075 Göttingen, Germany
Author to whom correspondence should be addressed.
These authors contributed equally.
Int. J. Mol. Sci. 2020, 21(15), 5373;
Received: 30 June 2020 / Revised: 23 July 2020 / Accepted: 27 July 2020 / Published: 28 July 2020
(This article belongs to the Special Issue Extracellular Vesicles: Biology and Potentials in Cancer Therapeutics)
Extracellular vesicles (EV) are secreted by all cell types in a tumor and its microenvironment (TME), playing an essential role in intercellular communication and the establishment of a TME favorable for tumor invasion and metastasis. They encompass a variety of vesicle populations, among them the well-known endosomal-derived small exosomes (Exo), but also larger vesicles (diameter > 100 nm) that are shed directly from the plasma membrane, the so-called microvesicles (MV). Increasing evidence suggests that MV, although biologically different, share the tumor-promoting features of Exo in the TME. Due to their larger size, they can be readily harvested from patients’ blood and characterized by routine methods such as conventional flow cytometry, exploiting the plethora of molecules expressed on their surface. In this review, we summarize the current knowledge about the biology and the composition of MV, as well as their role within the TME. We highlight not only the challenges and potential of MV as novel biomarkers for cancer, but also discuss their possible use for therapeutic intervention. View Full-Text
Keywords: microvesicles; biomarker; cancer; tumor microenvironment; therapy microvesicles; biomarker; cancer; tumor microenvironment; therapy
Show Figures

Figure 1

MDPI and ACS Style

Menck, K.; Sivaloganathan, S.; Bleckmann, A.; Binder, C. Microvesicles in Cancer: Small Size, Large Potential. Int. J. Mol. Sci. 2020, 21, 5373.

AMA Style

Menck K, Sivaloganathan S, Bleckmann A, Binder C. Microvesicles in Cancer: Small Size, Large Potential. International Journal of Molecular Sciences. 2020; 21(15):5373.

Chicago/Turabian Style

Menck, Kerstin, Suganja Sivaloganathan, Annalen Bleckmann, and Claudia Binder. 2020. "Microvesicles in Cancer: Small Size, Large Potential" International Journal of Molecular Sciences 21, no. 15: 5373.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop